Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongjun Chung

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|January 4, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancerNo-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon, et al.
Neuro-Oncology|August 28, 2025
Targeting TGFβ docking receptor Glycoprotein A Repetitions Predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastomaBill Xingjun Wu, Daniel Kreatsoulas, Hakan Cam, et al.
JCI Insight|November 2, 2019
O-GlcNAc transferase suppresses necroptosis and liver fibrosisBichen Zhang, Min-Dian Li, Ruonan Yin, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
JAMA Oncology|July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled TrialHelen J Ross, David Kozono, Xiaofei F Wang, et al.
The American Journal of Psychiatry|January 15, 2025
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in RatsBrittany N Kuhn, Nazzareno Cannella, Ayteria D Crow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbanceYunfan Yang, Xiruo Li, Harding H Luan, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A multi-symptomatic model of heroin use disorder in rats reveals distinct behavioral profiles and neuronal correlates of heroin vulnerability versus resiliencyBrittany N Kuhn, Nazzareno Cannella, Ayteria D Crow, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8<sup>+</sup> T cell antitumor immunityAnqi Li, Yuzhou Chang, No-Joon Song, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|January 4, 2024
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancerNo-Joon Song, Karthik B Chakravarthy, Hyeongseon Jeon, et al.
Neuro-Oncology|August 28, 2025
Targeting TGFβ docking receptor Glycoprotein A Repetitions Predominant (GARP) via novel chimeric antigen receptor (CAR)-T cell platform to treat glioblastomaBill Xingjun Wu, Daniel Kreatsoulas, Hakan Cam, et al.
JCI Insight|November 2, 2019
O-GlcNAc transferase suppresses necroptosis and liver fibrosisBichen Zhang, Min-Dian Li, Ruonan Yin, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
JAMA Oncology|July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled TrialHelen J Ross, David Kozono, Xiaofei F Wang, et al.
The American Journal of Psychiatry|January 15, 2025
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in RatsBrittany N Kuhn, Nazzareno Cannella, Ayteria D Crow, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2020
OGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbanceYunfan Yang, Xiruo Li, Harding H Luan, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
A multi-symptomatic model of heroin use disorder in rats reveals distinct behavioral profiles and neuronal correlates of heroin vulnerability versus resiliencyBrittany N Kuhn, Nazzareno Cannella, Ayteria D Crow, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8<sup>+</sup> T cell antitumor immunityAnqi Li, Yuzhou Chang, No-Joon Song, et al.
Pageof 12